Advertisement
RSPH vs XLV
Which ETF would AI Choose? Invesco S&P 500 Equal Weight Health Care ETF (RSPH) vs. Health Care Select Sector SPDR Fund (XLV)
Key Takeaways
- RSPH tracks an equal-weighted index of S&P 500 healthcare stocks and rebalances quarterly, promoting broader diversification across holdings compared to cap-weighted peers.
- XLV follows a market-capitalization-weighted index of the same sector, resulting in higher concentration in the largest companies and greater sensitivity to mega-cap performance.
- XLV offers a significantly lower expense ratio of 0.08% versus RSPH’s 0.40%, enhancing long-term cost efficiency for investors.
- Both ETFs provide targeted exposure to the healthcare sector, including pharmaceuticals, biotechnology, medical devices, and providers, but differ in risk profiles due to weighting methodologies.
- RSPH’s equal-weight approach may reduce single-stock concentration risk while potentially increasing exposure to smaller constituents within the S&P 500 healthcare universe.
- XLV’s structure supports higher liquidity and tighter bid-ask spreads, making it more suitable for larger or frequent trades.
Introduction
Investors seeking healthcare sector exposure often compare Invesco S&P 500 Equal Weight Health Care ETF (RSPH) and Health Care Select Sector SPDR Fund (XLV) because both target the same broad industry yet employ distinct indexing strategies. These ETFs do not compete directly as substitutes but instead offer alternative approaches to sector allocation: one emphasizes equal weighting for balanced representation, while the other prioritizes market-cap leadership. The comparison helps investors align choices with goals around diversification, cost, and exposure to healthcare innovation amid evolving regulatory and demographic trends.
Invesco S&P 500 Equal Weight Health Care ETF (RSPH) Overview
RSPH seeks to track the S&P 500 Equal Weight Health Care Index, which assigns equal weights to healthcare companies within the S&P 500 as classified by the Global Industry Classification Standard (GICS). The ETF holds approximately 61 stocks and rebalances quarterly to maintain equal weighting. Its expense ratio stands at 0.40%. As a passive, rules-based product, RSPH provides diversified exposure across pharmaceuticals, biotechnology, healthcare equipment, providers, and life sciences tools. Top holdings typically include names such as Moderna (MRNA), Illumina (ILMN), and Mettler-Toledo (MTD), with no single position dominating due to the equal-weight methodology. This structure distinguishes RSPH by mitigating concentration risk relative to cap-weighted alternatives.
Health Care Select Sector SPDR Fund (XLV) Overview
XLV seeks to track the Health Care Select Sector Index, representing the healthcare sector of the S&P 500 through market-capitalization weighting. The ETF holds approximately 60-63 stocks with an expense ratio of 0.08%. As a passive product from State Street Global Advisors, it delivers concentrated exposure to leading healthcare firms. Top holdings are dominated by large-capitalization names such as Eli Lilly (LLY), Johnson & Johnson (JNJ), and AbbVie (ABBV), which together can account for a substantial portion of assets. XLV’s cap-weighted approach aligns closely with broader market movements within the sector and supports high liquidity through its large asset base and trading volume.
Industry and Thematic Backdrop
The healthcare sector encompasses pharmaceuticals, biotechnology, medical devices, and services, driven by long-term catalysts including population aging, advances in drug development, and personalized medicine. Macroeconomic factors such as interest rate expectations, government healthcare policy, and patent dynamics influence capital flows and earnings cycles. Regulatory developments around drug pricing and innovation incentives introduce both opportunities and risks. Sector participants benefit from steady demand yet face volatility from clinical trial outcomes, competitive pressures, and reimbursement changes. Both ETFs capture these themes but through different lenses of diversification and concentration.
Performance and Positioning Comparison
In recent market cycles, RSPH’s equal-weight methodology has produced different return patterns than XLV by limiting the influence of any single mega-cap stock. XLV’s cap-weighted structure has historically amplified gains during periods when top holdings outperform, while RSPH offers more balanced participation across the sector. Volatility differences arise from concentration levels, with XLV potentially exhibiting tighter correlation to large-cap healthcare leaders. Positioning favors XLV for investors prioritizing cost efficiency and liquidity, whereas RSPH appeals to those seeking reduced single-name risk within the same sector universe. Relative performance often reflects sector rotation and earnings trends among constituents.
AI Screener
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener to refine your ETF research.
Tickeron AI Verdict
Tickeron’s AI would currently favor XLV with moderate probability due to its lower expense ratio, superior liquidity profile, and established track record in delivering cap-weighted sector exposure. While RSPH offers structural diversification benefits through equal weighting, the cost and liquidity advantages of XLV align more closely with broad investor preferences in the current environment. The assessment rests on observable factors including expense efficiency, diversification profile, and sector momentum consistency.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSPH is a StrongBuy and XLV is a StrongBuy.
RSPH's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for RSPH turned positive on October 12, 2026. Looking at past instances where RSPH's MACD turned positive, the stock continued to rise in 44 of 50 cases over the following month. The odds of a continued upward trend are 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 09, 2026. You may want to consider a long position or call options on RSPH as a result. In 74 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
Following a +0.99% 3-day Advance, the price is estimated to grow further. Considering data from situations where RSPH advanced for three days, in 252 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
The Aroon Indicator entered an Uptrend today. In 239 of 304 cases where RSPH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RSPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
RSPH broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
XLV in upward trend: price rose above 50-day moving average on October 09, 2026
XLV moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend. In 34 of 39 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 87%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on XLV as a result. In 75 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.
The Moving Average Convergence Divergence (MACD) for XLV just turned positive on October 09, 2026. Looking at past instances where XLV's MACD turned positive, the stock continued to rise in 40 of 48 cases over the following month. The odds of a continued upward trend are 83%.
The 10-day moving average for XLV crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 85%.
Following a +4.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where XLV advanced for three days, in 265 of 327 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Aroon Indicator entered an Uptrend today. In 223 of 271 cases where XLV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 82%.
Bearish Trend Analysis
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XLV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
XLV broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
| RSPH | XLV | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 80% | 1 day ago 84% |
| Stochastic ODDS (%) | 1 day ago 79% | 1 day ago 79% |
| Momentum ODDS (%) | 1 day ago 84% | 1 day ago 77% |
| MACD ODDS (%) | 1 day ago 88% | 1 day ago 83% |
| TrendWeek ODDS (%) | 1 day ago 81% | 1 day ago 82% |
| TrendMonth ODDS (%) | 1 day ago 82% | 1 day ago 84% |
| Advances ODDS (%) | 1 day ago 83% | 8 days ago 81% |
| Declines ODDS (%) | 4 days ago 77% | 4 days ago 82% |
| BollingerBands ODDS (%) | 1 day ago 80% | 1 day ago 85% |
| Aroon ODDS (%) | 1 day ago 79% | 1 day ago 82% |
Advertisement
RSPH and
Correlation & Price change
A.I.dvisor indicates that over the last year, RSPH has been closely correlated with BDX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if RSPH jumps, then BDX could also see price increases.
| Ticker / NAME | Correlation To RSPH | 1D Price Change % | ||
|---|---|---|---|---|
| RSPH | 100% | +0.94% | ||
| BDX - RSPH | 67% Closely correlated | +3.13% | ||
| SYK - RSPH | 63% Loosely correlated | +3.19% | ||
| STE - RSPH | 63% Loosely correlated | +4.85% | ||
| RMD - RSPH | 61% Loosely correlated | +2.79% | ||
| MDT - RSPH | 61% Loosely correlated | +3.83% | ||
More | ||||
XLV and
Correlation & Price change
A.I.dvisor indicates that over the last year, XLV has been closely correlated with LLY. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if XLV jumps, then LLY could also see price increases.